Shopping Cart
- Remove All
Your shopping cart is currently empty
5-(5-methyl-1H-1,2,4-triazol-3-yl)-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole can be used in the synthesis of heterocyclic compounds to inhibit HIF pathway activity.
![5-(5-methyl-1H-1,2,4-triazol-3-yl)-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole](/group3/M00/02/7D/CgoaEWY7L0yEMwYxAAAAABzAzlI640.png)
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | $31 | In Stock | |
| 25 mg | $54 | In Stock | |
| 50 mg | $81 | In Stock | |
| 100 mg | $120 | In Stock | |
| 500 mg | $297 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $30 | In Stock |
| Description | 5-(5-methyl-1H-1,2,4-triazol-3-yl)-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole can be used in the synthesis of heterocyclic compounds to inhibit HIF pathway activity. |
| Molecular Weight | 311.22 |
| Formula | C12H8F3N5O2 |
| Cas No. | 1570493-58-1 |
| Smiles | CC=1NC(C2=NC(=NO2)C3=CC=C(OC(F)(F)F)C=C3)=NN1 |
| Relative Density. | 1.477 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (160.66 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.